Ameritas Investment Partners’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $48.4K | Hold |
4,037
| – | – | ﹤0.01% | 2274 |
|
|
2026
Q1 | $33.8K | Hold |
4,037
| – | – | ﹤0.01% | 2329 |
|
|
2025
Q4 | $58.1K | Hold |
4,037
| – | – | ﹤0.01% | 2023 |
|
|
2025
Q3 | $39K | Hold |
4,037
| – | – | ﹤0.01% | 2320 |
|
|
2025
Q2 | $33.1K | Hold |
4,037
| – | – | ﹤0.01% | 2435 |
|
|
2025
Q1 | $28.9K | Hold |
4,037
| – | – | ﹤0.01% | 2396 |
|
|
2024
Q4 | $31.2K | Hold |
4,037
| – | – | ﹤0.01% | 2441 |
|
|
2024
Q3 | $42.3K | Hold |
4,037
| – | – | ﹤0.01% | 2289 |
|
|
2024
Q2 | $47.2K | Hold |
4,037
| – | – | ﹤0.01% | 2169 |
|
|
2024
Q1 | $85.1K | Hold |
4,037
| – | – | ﹤0.01% | 1842 |
|
|
2023
Q4 | $72.5K | Hold |
4,037
| – | – | ﹤0.01% | 1939 |
|
|
2023
Q3 | $66.4K | Buy |
4,037
+1,046
| +35% | +$19K | ﹤0.01% | 1928 |
|
|
2023
Q2 | $59.8K | Hold |
2,991
| – | – | ﹤0.01% | 1938 |
|
|
2023
Q1 | $56.6K | Hold |
2,991
| – | – | ﹤0.01% | 1894 |
|
|
2022
Q4 | $67.8K | Hold |
2,991
| – | – | ﹤0.01% | 1851 |
|
|
2022
Q3 | $79K | Hold |
2,991
| – | – | ﹤0.01% | 1670 |
|
|
2022
Q2 | $73K | Hold |
2,991
| – | – | ﹤0.01% | 1721 |
|
|
2022
Q1 | $99K | Hold |
2,991
| – | – | ﹤0.01% | 1662 |
|
|
2021
Q4 | $98K | Hold |
2,991
| – | – | ﹤0.01% | 1695 |
|
|
2021
Q3 | $125K | Hold |
2,991
| – | – | ﹤0.01% | 1555 |
|
|
2021
Q2 | $116K | Hold |
2,991
| – | – | ﹤0.01% | 1631 |
|
|
2021
Q1 | $102K | Hold |
2,991
| – | – | ﹤0.01% | 1658 |
|
|
2020
Q4 | $136K | Hold |
2,991
| – | – | 0.01% | 1382 |
|
|
2020
Q3 | $82K | Hold |
2,991
| – | – | ﹤0.01% | 1558 |
|
|
2020
Q2 | $110K | Hold |
2,991
| – | – | 0.01% | 1356 |
|
|
2020
Q1 | $97K | Buy |
2,991
+150
| +5% | +$6.25K | 0.01% | 1294 |
|
|
2019
Q4 | $116K | Hold |
2,841
| – | – | 0.01% | 1425 |
|
|
2019
Q3 | $101K | Hold |
2,841
| – | – | ﹤0.01% | 1465 |
|
|
2019
Q2 | $146K | Buy |
2,841
+236
| +9% | +$11.8K | 0.01% | 1260 |
|
|
2019
Q1 | $149K | Hold |
2,605
| – | – | 0.01% | 1216 |
|
|
2018
Q4 | $109K | Hold |
2,605
| – | – | 0.01% | 1316 |
|
|
2018
Q3 | $197K | Buy |
2,605
+222
| +9% | +$16K | 0.01% | 1094 |
|
|
2018
Q2 | $171K | Sell |
2,383
-33
| -1% | -$1.58K | 0.01% | 1168 |
|
|
2018
Q1 | $72K | Hold |
2,416
| – | – | ﹤0.01% | 1700 |
|
|
2017
Q4 | $80K | Hold |
2,416
| – | – | ﹤0.01% | 1633 |
|
|
2017
Q3 | $54K | Hold |
2,416
| – | – | ﹤0.01% | 1852 |
|
|
2017
Q2 | $48K | Buy |
2,416
+838
| +53% | +$16.2K | ﹤0.01% | 1933 |
|
|
2017
Q1 | $30K | Buy |
+1,578
| New | +$30.4K | ﹤0.01% | 2165 |
|
Other funds holding RGNX
RG
Ameritas Investment Partners's RGNX Position: Q2 2026 in Review
Ameritas Investment Partners held its Regenxbio (RGNX) position steady in Q2 2026 at 4,037 shares worth $48.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2274.
Ameritas Investment Partners first reported a position in RGNX in Q1 2017 and has held it in 38 quarters since. The position peaked at $197K in Q3 2018. 165 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.
- Ameritas Investment Partners held 4,037 shares of Regenxbio worth $48.4K as of Q2 2026.
- Ameritas Investment Partners left its Regenxbio share count unchanged in Q2 2026.
- Regenxbio made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q2 2026, its #2274 holding.
- Ameritas Investment Partners first reported a position in Regenxbio in Q1 2017 and has held it in 38 quarters since.
- Ameritas Investment Partners's Regenxbio position peaked at $197K in Q3 2018.
- 165 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.
Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.